Carine Claassen-Punt,Mark Alan Smith,Ling Chen,Ari Andrew Gershon
申请号：
US15926076
公开号：
US20180263911A1
申请日:
2018.03.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The disclosure is directed to methods of treating schizophrenia or bipolar disorder by subcutaneously administering a sustained-release dosage form of olanzapine, or a pharmaceutically acceptable salt thereof. Methods of subcutaneously administering olanzapine, or a pharmaceutically acceptable salt thereof, are also described.
